TP53 and neoplasm: As for others, such as somatic alterations, our result that the amplification of oncogene MYC and mutation of tumor suppressor gene TP53 are enriched in HGLO supports the idea that they were regarded as the driver of the initiation of tumor metabolic reprogramming [43, 44, 60].